SCHEMBL28355353

SCHEMBL28355353

FC(F)(F)c1ccc(-c2nc(-c3ccccc3)cs2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.68
KMT2A Q03164 5/20 0.68
AR P10275 2/20 0.68
SREBF2 Q12772 1/20 0.64
MEN1 O00255 4/20 0.61
NPSR1 Q6W5P4 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
ALDH1A1 P00352 3/20 0.60
RAB9A P51151 6/20 0.59
SMN1; SMN2 Q16637 4/20 0.59
NPC1 O15118 3/20 0.59
LTA4H P09960 1/20 0.56
MAPT P10636 2/20 0.56
LMNA P02545 2/20 0.55
POLB P06746 1/20 0.55
GAA P10253 1/20 0.55
PKM P14618 1/20 0.55
HPGD P15428 1/20 0.55
ALOX12 P18054 1/20 0.55
CYP19A1 P11511 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21462074 1.00 KDM4E (0.68) KDM4EKMT2AARSREBF2MEN1
SCHEMBL21479710 0.93 KDM4E (0.68) KDM4EKMT2AARSREBF2MEN1
SCHEMBL27810026 0.92 KMT2A (0.57) KDM4EKMT2AARSREBF2MEN1
SCHEMBL21479644 0.86 KMT2A (0.67) KDM4EKMT2AARSREBF2MEN1
SCHEMBL30279814 0.86 KMT2A (0.67) KDM4EKMT2AARSREBF2MEN1
SCHEMBL11212983 0.86 SREBF2 (0.82) KDM4EKMT2AARSREBF2MEN1
SCHEMBL11213828 0.86 SREBF2 (0.82) KDM4EKMT2AARSREBF2MEN1
SCHEMBL11215130 0.86 SREBF2 (0.82) KDM4EKMT2AARSREBF2MEN1
SCHEMBL28708805 0.86 LTA4H (0.62) KDM4EKMT2AARSREBF2MEN1
SCHEMBL15160564 0.86 KDM4E (0.71) KDM4EKMT2AARSREBF2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270199-A1 THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME ARKANSAS STATE UNIV JONESBORO (US) 2025-08-28 US disclosed
CN-110627739-B Method for synthesizing thiazole heterocyclic compound through photocatalysis 桂林医学院 2023-02-07 CN disclosed
CN-110627739-A Method for synthesizing thiazole heterocyclic compound through photocatalysis 桂林医学院 2019-12-31 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250270199-A1 THIAZOLE DERIVATIVES AND METHODS OF USING THE SAME TST, GOT2, TPMT KDM4E 4630/4885KMT2A 3923/4885AR 3042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.